{"organizations": [], "uuid": "5c2fc7024b4443a976a06962bee0686a646fb2c2", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180128.html", "section_title": "Archive News &amp; Video for Sunday, 28 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-strides-shasun-gets-us-fda-nod-for/brief-strides-shasun-gets-u-s-fda-nod-for-tenofovir-disoproxil-fumarate-tablets-idUSFWN1PN032", "country": "US", "domain_rank": 408, "title": "BRIEF-Strides Shasun Gets U.S. FDA Nod For Tenofovir Disoproxil Fumarate Tablets", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.823, "site_type": "news", "published": "2018-01-29T11:46:00.000+02:00", "replies_count": 0, "uuid": "5c2fc7024b4443a976a06962bee0686a646fb2c2"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-strides-shasun-gets-us-fda-nod-for/brief-strides-shasun-gets-u-s-fda-nod-for-tenofovir-disoproxil-fumarate-tablets-idUSFWN1PN032", "ord_in_thread": 0, "title": "BRIEF-Strides Shasun Gets U.S. FDA Nod For Tenofovir Disoproxil Fumarate Tablets", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}, {"name": "bangalore", "sentiment": "none"}, {"name": "co", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "strides shasun ltd", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 29 (Reuters) - Strides Shasun Ltd:\n* GETS U.S. FDA NOD FOR TENOFOVIR DISOPROXIL FUMARATE TABLETS\n* DRUG TO BE MANUFACTURED AT CO'S ORAL DOSAGE FACILITY IN BANGALORE Source text - bit.ly/2DXpeei Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2DXpeei"], "published": "2018-01-29T11:46:00.000+02:00", "crawled": "2018-01-29T21:56:53.027+02:00", "highlightTitle": ""}